Spain Ultrasound Devices Market Analysis by Mordor Intelligence
The Spain Ultrasound Devices Market size is estimated at USD 221.98 million in 2025, and is expected to reach USD 258.31 million by 2030, at a CAGR of 3.08% during the forecast period (2025-2030).
Public sources account for 71.7% of national health spending, so device purchasing decisions continuously balance universal‐coverage goals with cost‐effectiveness mandates. An aging population, the normalization of bedside imaging protocols after COVID-19, and rapid uptake of portable systems combine to sustain demand even as hospital capital budgets tighten. AI-guided workflow tools reduce operator dependence and accelerate throughput, encouraging both public and private providers to refresh installed fleets. At the same time, the EU Medical Device Regulation (MDR) and Spain’s AEMPS certification timelines raise compliance costs that slow the launch of premium systems. Market participants therefore prioritize platform interoperability, simplified training requirements, and clear cost-utility evidence to secure tenders across Spain’s autonomous regions.
Key Report Takeaways
- By application, radiology led with 37.85% revenue share of the Spain ultrasound devices market share in 2024, while Critical Care is projected to post the fastest 5.96% CAGR through 2030.
- By technology, 3D & 4D captured 41.56% of the Spain ultrasound devices market size in 2024, whereas high-intensity focused ultrasound is set to expand at a 5.45% CAGR to 2030.
- By portability, stationary systems accounted for 62.01% share of the Spain ultrasound devices market size in 2024, but hand-held/pocket devices are forecast to climb at a 7.34% CAGR through 2030.
- By end user, public hospitals commanded 39.33% of the Spain ultrasound devices market size in 2024, while home healthcare settings are advancing at a 6.83% CAGR to 2030.
Spain Ultrasound Devices Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Aging population and chronic disease burden | +0.8% | National; higher in rural provinces | Long term (≥ 4 years) |
| Point-of-care and handheld ultrasound uptake | +0.6% | Early acceleration in Andalusia, Canary, Madrid | Medium term (2-4 years) |
| Oncology and cardiac service capacity build-outs | +0.4% | Castilla y León, Valencia, Catalonia | Medium term (2-4 years) |
| AI-enabled workflow optimization | +0.3% | Barcelona, Madrid, Sevilla | Short term (≤ 2 years) |
| Post-COVID bedside imaging standardization | +0.2% | All autonomous regions | Short term (≤ 2 years) |
| Tele-ultrasound pilots in remote islands | +0.1% | Canary, Balearic, rural interiors | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Aging population and chronic disease burden
Rising life expectancy lifts ultrasound demand across cardiology, endocrinology, and musculoskeletal care. The European Central Bank projects aging-related health costs to climb by 7 percentage points of GDP by 2070, placing diagnostic efficiency at the center of budget planning. AI-assisted muscle assessment already achieves 82.3% accuracy in detecting malnutrition-linked sarcopenia, illustrating how advanced algorithms help physicians manage geriatric syndromes with limited scan time.[1]Juan Martinez et al., “AI Muscle Ultrasound Accuracy in Elderly Nutrition,” MDPI Nutrients, mdpi.com
Point-of-care and handheld ultrasound uptake
The Andalusian health service has trained more than 1,000 primary-care clinicians in abdominal scanning, reinforcing policy momentum for bedside imaging programs.[2]Servicio Andaluz de Salud, “Plan de Formación en Ecografía Abdominal,” juntadeandalucia.es Comparative evaluations of devices like Vscan Air and SonoEye confirm diagnostic performance on par with full-size consoles, encouraging hospitals to adopt “probe-first” triage pathways. Structured POCUS guidance from WONCA Europe underscores the technology’s role in closing rural care gaps.
Oncology and cardiac service capacity build-outs
A EUR 120 (USD 139) million European Investment Bank loan is modernizing five Castilla y León hospitals, expanding imaging suites that favor multipurpose ultrasound systems.[3]European Investment Bank, “Hospital Modernization Castilla y León,” eib.org Galicia’s electronic cardiology consultation program cut waiting times by 51.8% for complex oncology patients, demonstrating how integrated ultrasound pathways relieve specialist bottlenecks. Instituto Cartuja’s adoption of MR-guided focused ultrasound for uterine fibroids showcases therapeutic opportunities beyond diagnostics.
AI-enabled workflow optimization
Spanish centers are piloting AI guidance that lets non-sonographer nurses diagnose deep vein thrombosis with up to 98% sensitivity, tackling staffing shortages during night shifts. Another multicenter study reached 94% patient-level accuracy in infant meningitis screening, suggesting AI can reduce invasive lumbar punctures. Government research grants confirm national commitment to algorithm-ready imaging ecosystems.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| EU MDR and AEMPS approval timelines | -0.4% | National; affects all manufacturers | Long term (≥ 4 years) |
| Public procurement price pressure | -0.3% | High in regions with tight budgets | Medium term (2-4 years) |
| Shortage of accredited sonographers | -0.2% | Acute in rural and island territories | Long term (≥ 4 years) |
| Hospital CAPEX reallocation post-COVID | -0.1% | Public hospitals nationwide | Short term (≤ 2 years) |
| Source: Mordor Intelligence | |||
EU MDR and AEMPS approval timelines
Low certification throughput under the new regulation has extended market-entry cycles. The Medical Device Coordination Group noted backlog risks through 2025, prompting manufacturers to reroute launch budgets toward post-market surveillance rather than innovation. Spain’s AEMPS adds localized clinical data requirements, stretching smaller companies’ resources.
Public procurement price pressure
Value-based tendering emphasizes outcomes, yet hospital committees still gravitate to lowest-price bids when evidence is inconclusive. Health-technology assessors apply cost-effectiveness thresholds below EUR 30,000 (USD 34,929) per life-year gained, filtering out premium consoles lacking head-to-head savings data. Providers therefore favor versatile systems that cover multiple disciplines with minimal accessory spend.
Segment Analysis
By Application: Critical Care expands bedside imaging horizons
Radiology remained the largest contributor, holding 37.85% of Spain ultrasound devices market share in 2024. Critical Care, while smaller, is projected to deliver a 5.96% CAGR thanks to mandatory ultrasound competencies in intensive-care residency programs. Spain ultrasound devices market size for critical care is on track to bridge the capacity gap created by rising admissions of multimorbid elderly patients. Hospitals equip shock management teams with handheld probes that facilitate rapid fluid-status checks and cardiac function snapshots. Meanwhile, cardiology leverages electronic consultation models to accelerate echo interpretation, and gynecology/obstetrics integrates AI Doppler analytics to shorten prenatal visits. Musculoskeletal and rheumatology practitioners have raised ultrasound adoption to 90% of practice units, reflecting clinician comfort with in-office joint evaluation. Urology and vascular labs seize focused ultrasound for non-invasive ablation, and emergency departments rely on portable scanners for rule-out protocols in trauma bays.
Spain ultrasound devices market participants recognize that cross-department sharing of consoles boosts utilization rates, a key tender criterion. Structured accreditation from the Spanish Society of Intensive Medicine underpins consistent image quality, while AI decision support reduces inter-observer variability. As reimbursement moves toward bundled-care models, multispecialty ultrasound applications will remain central to cost-containment strategies.
Note: Segment shares of all individual segments available upon report purchase
By Technology: HIFU redefines therapeutic potential
3D & 4D imaging secured 41.56% of Spain ultrasound devices market size in 2024, driven by obstetric volume and oncologic staging needs. High-intensity Focused Ultrasound is poised for a 5.45% CAGR, reflecting Instituto Cartuja’s success with MRgFUS uterine fibroid therapy and the CE extension for adenomyosis. Spain ultrasound devices market stakeholders note that HIFU’s non-invasive nature lowers postoperative stays, aligning with value-based care metrics. Conventional 2D imaging persists in primary care, where the Canary Islands deployment verifies its relevance for broad access. Doppler innovation accelerates through AI auto-classification that trims fetal-monitoring workflow time. Wireless and smartphone-linked probes broaden research participation and support remote training, offsetting the shortage of academic sonographers.
Developers focus on open-source operating systems that cut licensing expenses and encourage agile upgrades. This orientation complements Spain’s need for long hardware life cycles and future-proofed connectivity amid evolving MDR software classifications.
By Portability: Handheld probes shift scanning to the patient
Stationary consoles retain 62.01% share, anchored by tertiary-center radiology suites. Nevertheless, handheld scanners project a 7.34% CAGR, fueled by improvements in B-mode resolution and battery autonomy. Spain ultrasound devices market stakeholders observe that emergency physicians using Butterfly iQ+ reached 91.7% sensitivity for retinal-detachment detection, and prehospital crews achieved 79.5% agreement with in-hospital findings during trauma transfer. Cart-based portables serve mixed-acuity wards, balancing power and mobility. Wireless advances minimize infection-control steps, a post-COVID purchasing imperative.
Handheld makers emphasize subscription pricing that bundles cloud archiving and AI triage, lowering upfront barriers. Health regions with dispersed clinics such as Extremadura and Aragón prioritize pocket models that sync to electronic health records over cellular networks, ensuring clinical documentation continuity.
Note: Segment shares of all individual segments available upon report purchase
By End User: Home healthcare captures decentralized demand
Public Hospitals remained the largest customers with 39.33% of Spain ultrasound devices market size in 2024. Yet Home Healthcare Settings show a 6.83% CAGR, buoyed by telemedicine platforms that integrate high-definition video with ultrasound feeds. La Palma’s program saved more than EUR 1 (USD 1.16) million in annual travel costs, demonstrating economic viability. Private Hospitals harness premium imaging for specialty services such as reproductive medicine, while diagnostic centers streamline throughput via AI triage that flags normal exams for rapid reporting. Emergency medical services and mobile units deploy ruggedized probes to improve triage at mass-casualty scenes.
Remote-guided scanning protocols allow family physicians to consult specialists in real time, expanding ultrasound’s footprint beyond traditional brick-and-mortar sites. Device makers now collaborate with telecom operators to guarantee bandwidth in mountainous areas, an essential step to sustaining image fidelity during home visits.
Geography Analysis
Spain ultrasound devices market exhibits pronounced regional patterns shaped by autonomous budgeting and geography. Andalusia leads primary-care integration with over 1,000 clinicians certified in abdominal ultrasound, resulting in faster referrals for hepatobiliary diseases. The Canary archipelago pioneered a network of 57 primary-care ecographs linked to radiologists on the mainland, lowering diagnostic delays for island residents. Madrid and Barcelona host research clusters that test AI-driven workflow engines financed by the national digital-transformation agenda.
Valencia’s flood response during the 2024 DANA storms validated the resilience of portable systems that continued operating despite power limitations. Galicia’s e-cardiology consultations trimmed waitlists for oncology patients needing echo clearance, demonstrating how digital tools expedite imaging access.
Overall, Spain ultrasound devices market participants tailor go-to-market plans to each region’s procurement norms and clinical priorities. Island territories require rugged, lightweight probes with cloud connectivity, while metropolitan centers demand AI-rich consoles that streamline radiology throughput. The coexistence of these needs ensures a steady replacement cycle through the forecast horizon.
Competitive Landscape
Competition is moderately fragmented. Global conglomerates leverage full-line portfolios and extensive service networks, while local disruptors target portability and AI niches. Product differentiation centers on embedded decision support, wireless data security, and cross-modality integration rather than list price. Partnerships between hospital consortia and software start-ups have yielded AI guidance modules that reach 98% sensitivity for deep vein thrombosis detection, reducing reliance on scarce sonographers. Such collaborations shorten learning curves and strengthen vendor lock-in.
High-intensity Focused Ultrasound suppliers cultivate alliances with gynecology clinics to showcase non-invasive fibroid therapy outcomes. Handheld innovators partner with medical schools to embed POCUS curricula, generating early-career brand loyalty. MDR compliance represents both a moat and a cost burden; firms with mature quality systems secure certificates sooner, capturing share while smaller rivals await notified-body slots. Pricing strategies increasingly bundle service, AI updates, and cloud archiving into multiyear subscriptions, aligning vendor revenue with customer usage.
White-space opportunities lie in rural connectivity solutions, adaptive training platforms, and specialized probes for oncology guidance. Vendors that prove real-world economic gains such as reduced patient transfers strengthen their positions in Spain ultrasound devices market.
Spain Ultrasound Devices Industry Leaders
-
Canon Medical Systems Corporation
-
Fujifilm Holdings Corporation
-
GE Healthcare
-
Siemens Healthineers AG
-
Koninklijke Philips N.V.
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- April 2025: The ALS Association and the Focused Ultrasound Foundation have announced the launch of a two-stage pilot clinical trial in Barcelona, Spain, aimed at exploring focused ultrasound neuromodulation as a potential treatment for non-familial amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.This collaborative research initiative marks a significant step toward advancing therapeutic options for ALS, a progressive neurodegenerative disease with limited treatment pathways.
- September 2024: Butterfly Network Inc., a leading digital health innovator, has announced the commercial launch of its third-generation handheld point-of-care ultrasound (POCUS) system, the Butterfly iQ3, across 17 European countries, effective September 4, 2024.The Butterfly iQ3 is now available in Spain, marking a significant expansion of Butterfly’s footprint in Europe.
Spain Ultrasound Devices Market Report Scope
As per the scope of the report, ultrasound devices are used for an imaging method that creates images of various body structures using high-frequency sound waves. They are used to evaluate a variety of disorders relating to the liver, kidneys, and other abdominal conditions, including usage in pregnancy. As a result, these devices have a variety of uses in the medical area, including diagnostic imaging and therapeutic modality. Spain's ultrasound device market is segmented by application, technology, and type. Based on application the market is segmented as anesthesiology, cardiology, gynecology/obstetrics, musculoskeletal, radiology, critical care, and other applications). Based on technology the market is segmented into 2D ultrasound imaging, 3D and 4D ultrasound imaging, doppler imaging, and high-intensity focused ultrasound. Based on type the market is segmented as stationary ultrasound and portable ultrasound. The report offers the value (in USD) for all the above segments.
| Anesthesiology |
| Cardiology |
| Gynecology / Obstetrics |
| Musculoskeletal |
| Radiology |
| Critical Care |
| Urology |
| Vascular |
| Other Applications |
| 2D Ultrasound Imaging |
| 3D & 4D Ultrasound Imaging |
| Doppler Imaging |
| High-Intensity Focused Ultrasound |
| Other Technologies |
| Stationary Systems |
| Portable Cart-based Systems |
| Hand-held / Pocket Devices |
| Public Hospitals |
| Private Hospitals & Clinics |
| Diagnostic Imaging Centres |
| Home Healthcare Settings |
| Other End Users |
| By Application | Anesthesiology |
| Cardiology | |
| Gynecology / Obstetrics | |
| Musculoskeletal | |
| Radiology | |
| Critical Care | |
| Urology | |
| Vascular | |
| Other Applications | |
| By Technology | 2D Ultrasound Imaging |
| 3D & 4D Ultrasound Imaging | |
| Doppler Imaging | |
| High-Intensity Focused Ultrasound | |
| Other Technologies | |
| By Portability | Stationary Systems |
| Portable Cart-based Systems | |
| Hand-held / Pocket Devices | |
| By End User | Public Hospitals |
| Private Hospitals & Clinics | |
| Diagnostic Imaging Centres | |
| Home Healthcare Settings | |
| Other End Users |
Key Questions Answered in the Report
What is the current value of the Spain ultrasound devices market?
The market is valued at USD 221.98 million in 2025 and is projected to reach USD 258.31 million by 2030.
Which application area contributes the largest revenue?
Radiology leads with 37.85% revenue share in 2024.
Which segment is growing fastest by portability?
Hand-held/Pocket devices are advancing at a 7.34% CAGR through 2030.
How does EU MDR affect ultrasound device suppliers in Spain?
Extended certification timelines and added clinical evidence requirements delay product launches and raise compliance costs.
Why are home healthcare providers investing in ultrasound?
Telemedicine frameworks and AI guidance let caregivers perform scans at patients’ homes, cutting travel time and easing hospital capacity constraints.
What technological trend is disrupting traditional therapy?
High-intensity Focused Ultrasound offers non-invasive treatment for conditions like uterine fibroids, spurring a 5.45% CAGR within the technology segment.
Page last updated on: